268 related articles for article (PubMed ID: 21958602)
21. A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States.
Escoffery C; Rodgers KC; Kegler MC; Haardörfer R; Howard DH; Liang S; Pinsker E; Roland KB; Allen JD; Ory MG; Bastani R; Fernandez ME; Risendal BC; Byrd TL; Coronado GD
BMC Public Health; 2014 Mar; 14():274. PubMed ID: 24661503
[TBL] [Abstract][Full Text] [Related]
22. Receipt, uptake, and satisfaction with tailored DVD and patient navigation interventions to promote cancer screening among rural women.
Rawl SM; Baltic R; Monahan PO; Stump TE; Hyer M; Ennis AC; Walunis J; Renick K; Hinshaw K; Paskett ED; Champion VL; Katz ML
Transl Behav Med; 2023 Dec; 13(12):879-890. PubMed ID: 37708322
[TBL] [Abstract][Full Text] [Related]
23. Key indicators of organized cancer screening programs: Results from a Delphi study.
Csanádi M; de Kok IM; Heijnsdijk EA; Anttila A; Heinävaara S; Pitter JG; Széles G; Ivanuš U; Priaulx J; Veerus P; Senore C; Koning HJ; Vokó Z
J Med Screen; 2019 Sep; 26(3):120-126. PubMed ID: 30621498
[No Abstract] [Full Text] [Related]
24. NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.
Steinwachs D; Allen JD; Barlow WE; Duncan RP; Egede LE; Friedman LS; Keating NL; Kim P; Lave JR; LaVeist TA; Ness RB; Optican RJ; Virnig BA
NIH Consens State Sci Statements; 2010 Feb; 27(1):1-31. PubMed ID: 20140035
[TBL] [Abstract][Full Text] [Related]
25. Methods to increase participation in organised screening programs: a systematic review.
Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
[TBL] [Abstract][Full Text] [Related]
26. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study.
Kotzur M; McCowan C; Macdonald S; Wyke S; Gatting L; Campbell C; Weller D; Crighton E; Steele RJC; Robb KA
BMJ Qual Saf; 2020 Jun; 29(6):482-490. PubMed ID: 31879320
[TBL] [Abstract][Full Text] [Related]
27. Cervical screening: a guideline for clinical practice in Ontario.
Murphy J; Kennedy EB; Dunn S; McLachlin CM; Kee Fung MF; Gzik D; Shier M; Paszat L
J Obstet Gynaecol Can; 2012 May; 34(5):453-458. PubMed ID: 22555138
[TBL] [Abstract][Full Text] [Related]
28. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
29. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
30. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
31. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
[TBL] [Abstract][Full Text] [Related]
32. ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Chan WV; Pearson TA; Bennett GC; Cushman WC; Gaziano TA; Gorman PN; Handler J; Krumholz HM; Kushner RF; MacKenzie TD; Sacco RL; Smith SC; Stevens VJ; Wells BL; Castillo G; Heil SK; Stephens J; Jacobson Vann JC
Circulation; 2017 Feb; 135(9):e122-e137. PubMed ID: 28126839
[TBL] [Abstract][Full Text] [Related]
33. A grey literature review of special events for promoting cancer screenings.
Escoffery C; Rodgers KC; Kegler MC; Ayala M; Pinsker E; Haardörfer R
BMC Cancer; 2014 Jun; 14():454. PubMed ID: 24942822
[TBL] [Abstract][Full Text] [Related]
34. Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada.
Vahabi M; Lofters AK; Kopp A; Glazier RH
Cancer Causes Control; 2021 Feb; 32(2):147-155. PubMed ID: 33392906
[TBL] [Abstract][Full Text] [Related]
35. Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review.
Zabih V; Kahane A; O'Neill NE; Ivers N; Nathan PC
J Cancer Surviv; 2019 Oct; 13(5):713-729. PubMed ID: 31338733
[TBL] [Abstract][Full Text] [Related]
36. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.
Beaber EF; Kim JJ; Schapira MM; Tosteson AN; Zauber AG; Geiger AM; Kamineni A; Weaver DL; Tiro JA;
J Natl Cancer Inst; 2015 Jun; 107(6):djv120. PubMed ID: 25957378
[TBL] [Abstract][Full Text] [Related]
37. The influence of health systems on breast, cervical and colorectal cancer screening: an overview of systematic reviews using health systems and implementation research frameworks.
Priaulx J; Turnbull E; Heijnsdijk E; Csanádi M; Senore C; de Koning HJ; McKee M
J Health Serv Res Policy; 2020 Jan; 25(1):49-58. PubMed ID: 31284772
[No Abstract] [Full Text] [Related]
38. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
[TBL] [Abstract][Full Text] [Related]
39. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
[TBL] [Abstract][Full Text] [Related]
40. Effect of financial incentives on breast, cervical and colorectal cancer screening delivery rates: Results from a systematic literature review.
Mauro M; Rotundo G; Giancotti M
Health Policy; 2019 Dec; 123(12):1210-1220. PubMed ID: 31587819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
